About
Hengenix Biotech, Inc., located in Milpitas, CA, focuses on developing and delivering high-quality, innovative, and affordable medicine to patients worldwide to treat a range of chronic and life-threatening diseases with a focus in oncology and autoimmune diseases. Hengenix is affiliated with Shanghai Henlius Biotech, a global biopharmaceutical company established in 2010.
Our goal at Hengenix is to accelerate the discovery and development of innovative biologics (such as monoclonal and bispecific antibody) through technical and operational excellence and to build a leading immuno-oncology franchise with a diverse and distinguished product portfolio. We aim to be a globally trusted biotech company dedicated to bringing affordable, innovative treatment to patients with unmet medical needs worldwide.